Significant Ownership of COLUMN GROUP II, LP
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for COLUMN GROUP II, LP focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- /s/ James Evangelista, Attorney-in-Fact - James Evangelista, Attorney-in-Fact
- Manager location
- San Francisco, CA
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow COLUMN GROUP II, LP with Pro and return when a new Schedule 13D/G filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
CIK context first
Continue from COLUMN GROUP II, LP
Significant Ownership of COLUMN GROUP II, LP
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| RAPT | RAPT Therapeutics, Inc. | Common Stock, $0.0001 par value | 4.9% | $1,395,126 | 1,603,593 | Peter Svennilson | 23 Dec 2024 | ||
| ORIC | ORIC Pharmaceuticals, Inc. | Common Stock, $0.0001 par value per share | 3.7% | $48,612,534 | 3,644,118 | Peter Svennilson | 30 Sep 2025 |
Schedules 13D/G Reported by COLUMN GROUP II, LP:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.